Call Options

6 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2021

Feb 10, 2022

SELL
$7.1 - $12.82 $106,500 - $192,300
-15,000 Closed
0 $0
Q3 2021

Nov 10, 2021

SELL
$7.64 - $12.49 $114,600 - $187,350
-15,000 Reduced 50.0%
15,000 $165,000
Q2 2021

Aug 11, 2021

BUY
$8.68 - $27.49 $23,080 - $73,095
2,659 Added 9.73%
30,000 $260,000
Q1 2021

May 11, 2021

BUY
$12.0 - $27.64 $172,092 - $396,385
14,341 Added 110.32%
27,341 $416,000
Q4 2020

Feb 08, 2021

SELL
$11.05 - $16.62 $108,290 - $162,876
-9,800 Reduced 42.98%
13,000 $152,000
Q3 2020

Nov 02, 2020

BUY
$11.69 - $14.54 $266,532 - $331,512
22,800 New
22,800 $291,000

Others Institutions Holding CVM

About CEL SCI CORP


  • Ticker CVM
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,367,500
  • Market Cap $33.4M
  • Description
  • CEL-SCI Corporation engages in the research and development of immunotherapy for the treatment of cancer and infectious diseases. The company's lead investigational immunotherapy is Multikine, which is under phase III clinical trial for the treatment of head and neck cancer. Its Ligand Epitope Antigen Presentation System (LEAPS), a pre-clinical ...
More about CVM
Track This Portfolio

Track Iridian Asset Management LLC Portfolio

Follow Iridian Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Iridian Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Iridian Asset Management LLC with notifications on news.